Equities analysts expect RTI Surgical Inc (NASDAQ:RTIX) to announce earnings of $0.01 per share for the current quarter, Zacks reports. Two analysts have provided estimates for RTI Surgical’s earnings. The highest EPS estimate is $0.02 and the lowest is $0.00. The company is expected to issue its next quarterly earnings report on Tuesday, October 24th.

On average, analysts expect that RTI Surgical will report full-year earnings of $0.05 per share for the current financial year, with EPS estimates ranging from $0.04 to $0.06. For the next year, analysts forecast that the business will report earnings of $0.10 per share. Zacks’ earnings per share averages are a mean average based on a survey of analysts that that provide coverage for RTI Surgical.

RTI Surgical (NASDAQ:RTIX) last posted its earnings results on Tuesday, August 8th. The medical equipment provider reported $0.02 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.02. The firm had revenue of $72.10 million during the quarter, compared to analyst estimates of $70.25 million. RTI Surgical had a negative net margin of 2.34% and a negative return on equity of 6.40%. The firm’s revenue was up 6.7% compared to the same quarter last year.

A number of brokerages recently issued reports on RTIX. BidaskClub cut shares of RTI Surgical from a “buy” rating to a “hold” rating in a research report on Tuesday, August 8th. ValuEngine upgraded shares of RTI Surgical from a “sell” rating to a “hold” rating in a research report on Friday, June 2nd. Finally, Zacks Investment Research upgraded shares of RTI Surgical from a “sell” rating to a “hold” rating in a research report on Thursday, May 11th.

Shares of RTI Surgical (RTIX) traded up 1.14% during mid-day trading on Friday, hitting $4.45. 68,550 shares of the stock were exchanged. RTI Surgical has a 1-year low of $2.50 and a 1-year high of $6.00. The firm’s market cap is $262.70 million. The company’s 50-day moving average is $5.02 and its 200-day moving average is $4.68.

In related news, EVP John N. Varela acquired 12,000 shares of the firm’s stock in a transaction on Friday, August 11th. The shares were purchased at an average price of $4.85 per share, with a total value of $58,200.00. Following the acquisition, the executive vice president now directly owns 47,998 shares in the company, valued at $232,790.30. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Nicholas J. Valeriani acquired 5,500 shares of the firm’s stock in a transaction on Monday, August 21st. The shares were bought at an average cost of $4.70 per share, for a total transaction of $25,850.00. Following the acquisition, the director now owns 47,754 shares in the company, valued at $224,443.80. The disclosure for this purchase can be found here. 4.90% of the stock is owned by corporate insiders.

A number of large investors have recently modified their holdings of the business. Rutabaga Capital Management LLC MA bought a new stake in RTI Surgical during the 2nd quarter worth about $4,939,000. State Street Corp grew its holdings in RTI Surgical by 10.4% during the 2nd quarter. State Street Corp now owns 1,123,603 shares of the medical equipment provider’s stock worth $6,577,000 after acquiring an additional 106,204 shares during the last quarter. Goldman Sachs Group Inc. grew its holdings in RTI Surgical by 2.1% during the 2nd quarter. Goldman Sachs Group Inc. now owns 87,767 shares of the medical equipment provider’s stock worth $513,000 after acquiring an additional 1,782 shares during the last quarter. Krensavage Asset Management LLC grew its holdings in RTI Surgical by 0.6% during the 2nd quarter. Krensavage Asset Management LLC now owns 4,465,086 shares of the medical equipment provider’s stock worth $26,121,000 after acquiring an additional 26,136 shares during the last quarter. Finally, Brandywine Global Investment Management LLC bought a new stake in RTI Surgical during the 2nd quarter worth about $183,000. 69.99% of the stock is currently owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: “Zacks: Brokerages Expect RTI Surgical Inc (RTIX) to Post $0.01 EPS” was published by American Banking News and is the property of of American Banking News. If you are reading this news story on another publication, it was illegally copied and republished in violation of United States & international copyright law. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2017/09/08/zacks-brokerages-expect-rti-surgical-inc-rtix-to-post-0-01-eps.html.

RTI Surgical Company Profile

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Get a free copy of the Zacks research report on RTI Surgical (RTIX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for RTI Surgical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc and related companies with MarketBeat.com's FREE daily email newsletter.